The Patent Finder
US

Methods of Manufacturing Viscous Liquid Pharmaceutical Formulations

US 9,724,293 Lapsed on the fee record
OverviewFamilyAssignmentsSources & methods

Lapsed Aug 8, 2021 on the fee record · High confidence

First maintenance fee unpaid; grace period ended.

Filed Aug 29, 2012 as application 13/598,405 · Granted Aug 8, 2017
Base term, 20 years from filing
Today
Lapsed Aug 8, 2021
2004 2026
Clock starts
Nov 15, 2004
No longer in force
Aug 8, 2021
Granted
Aug 8, 2017
Term would have run to
Nov 15, 2024
base term after the term ends Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
0 of 1
Maintenance fees paid
One maintenance fee can end this term early, the one due 3.5 years from grant; the next one's grace period runs past the term end. This counts it if the record shows it paid.
9
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.

Its term would have run to Nov 15, 2024: its 20-year base term, with no adjustment for prosecution delay. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Nov 15, 2004, when application 10/988,716, the earliest non-provisional in its chain, was filed (this one was filed Aug 29, 2012)Nov 15, 2024High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capNone on recordno cap appliedHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events0 of 1 maintenance fees paidlapsed Aug 8, 2021High confidence
Computed term endThe steps above, in orderAug 8, 2021High confidence

This family

Application 10/742,730Abandoned
not computed
not computed
US 7,731,947In force
May 2028
May 2028
Application PCT/US2004/038409PCT application
no patent term
no patent term
Application 12/315,194Abandoned
not computed
not computed
US 7,964,183Term ended
Nov 2024
Nov 2024
US 8,257,691Term ended
Nov 2024
Nov 2024
US 8,398,967Term ended
May 2024
May 2024
US 9,724,293this patent
Aug 2021
Aug 2021
8 of 9 applications in this family shown, earliest filings first. Every application listed has its file history here. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Nov 14, 2012
Reel 29299, frame 678
Intarcia Therapeutics, Inc.U.S. Bank National Association, as Collateral AgentSecurity Agreement
Jul 9, 2013
Reel 30758, frame 932
Eliaz, Rom Ezer; Zhang, Yuanpeng; Rohloff, Catherine Manya; Weeks, Eric William; Junnarkar, GunjanAlza CorporationAssignment of Assignor's Interest
Jul 9, 2013
Reel 30759, frame 59
Alza CorporationIntarcia Therapeutics, Inc.Assignment of Assignor's Interest
Oct 23, 2015
Reel 36942, frame 544
U.S. Bank National Association, as Collateral AgentIntarcia Therapeutics, Inc.Release of Security Interest
Oct 9, 2019
Reel 50673, frame 20
Intarcia Therapeutics, Inc.; Intarcia Ireland LimitedMidcap Financial Trust, As AgentSecurity Interest
Oct 23, 2019
Reel 50801, frame 267
Intarcia Therapeutics, Inc.Baupost Private Investments Bviv-3, L.L.C., as Collateral AgentSecurity Interest
Jan 29, 2020
Reel 51739, frame 453
Baupost Private Investments Bviv-3, L.L.C. as Collateral AgentIntarcia Therapeutics, Inc.Release of Security Interest
Apr 17, 2020
Reel 52433, frame 1
Midcap Financial Trust, As AgentIntarcia Therapeutics, Inc.; Intarcia Ireland LimitedRelease of Security Interest
Apr 17, 2020
reel/frame not recorded
Midcap Financial Trust, As AgentIntarcia Therapeutics, Inc.Release of Security Interest
Apr 17, 2020
reel/frame not recorded
Midcap Financial Trust, As AgentIntarcia Ireland LimitedRelease of Security Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited